Accendra Health, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$709M
Gross Profit
$323M
Operating Income
$990K
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) |
|---|---|
| Revenue | $709M |
| COGS | $386M |
| Gross Profit | $323M |
| R&D | $0 |
| SG&A | $271M |
| D&A | $30M |
| Other OpEx | $21M |
| Operating Income | $990K |
| Interest Exp. | $990K |
| Other Non-Op | $0 |
| Pretax Income | $0 |
| Tax | $0 |
| Net Income | $0 |
QuarterCharts · SEC EDGAR data · ACH · Comparing FY2025 (Q4) vs FY2024 (Q4)